Synergetics USA (SURG) Misses Q1 EPS by 2c

Synergetics USA (NASDAQ: SURG) reported Q1 EPS of $0.00, $0.02 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $16.6 million versus the consensus estimate of $15.76 million.

For earnings history and earnings-related data on Synergetics USA (SURG) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• ITG (ITG) Tops Q2 EPS by 1c
• Spruce Biosciences (SPRB) PT Lowered to $144 at Citizens on Higher OpEx, Net Loss